H1N1 Infection – Global Pipeline Insight, 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “H1N1 infection – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive…
Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “H1N1 infection – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive…
A new website shares how The PCCA Standard applies to the company’s sourcing of chemicals, quality assurance and quality control,…
SBIR-funded companies will showcase biotechnology breakthroughs at BIO 2019 International Convention WASHINGTON–(BUSINESS WIRE)–The Biotechnology Innovation Organization (BIO) and the National…
DUBLIN–(BUSINESS WIRE)–The “HPC, Data Analysis, Storage & Management Market in Life Sciences By Products & Services (Data Analysis, Cloud Computing),…
The premier healthcare incubator collaborates with industry-leading AI company to help healthcare organizations find the right collaborators. CHICAGO–(BUSINESS WIRE)–MATTER, the…
PITTSBURGH–(BUSINESS WIRE)–ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute…
V114 Met Primary Endpoint by Demonstrating Noninferiority to PCV13 for all Shared Serotypes, and an Immune Response for Two Additional…
ANN ARBOR, Mich.–(BUSINESS WIRE)–Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage biopharmaceutical company developing novel treatments for orphan endocrine diseases, announced…
STONY BROOK, N.Y.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24apdn&src=ctag" target="_blank"gt;$apdnlt;/agt; lt;a href="https://twitter.com/hashtag/anticounterfeiting?src=hash" target="_blank"gt;#anticounterfeitinglt;/agt;–Applied DNA Sciences, Inc. (NASDAQ:APDN), announced today that American & Efird (A&E),…
Genprex takes next steps toward identifying drug name for future commercialization AUSTIN, Texas & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Genprex, Inc. (NASDAQ: GNPX),…